Chen, Rongqing
Lovas, András
Bakos, Péter
Molnár, Tamás
Hawchar, Fatime
Benyó, Balázs
Zhao, Zhanqi
Chase, J. Geoffrey
Rupitsch, Stefan J.
Moeller, Knut
Funding for this research was provided by:
Bundesministerium für Gesundheit (ERA PerMED 2522FSB903, ERA PerMED 2522FSB903)
H2020 Marie Skłodowska-Curie Actions (Rise DCPM 872488, Rise DCPM 872488, Rise DCPM 872488, Rise DCPM 872488)
National Research, Development and Innovation Office (OTKA K137995)
Albert-Ludwigs-Universität Freiburg im Breisgau
Article History
Received: 25 July 2024
Accepted: 10 September 2024
First Online: 16 September 2024
Declarations
:
: This study was approved by the Human Investigation Review Board of the University of Szeged with approval number 87/2020-SZTE as a part of a pre-registered trial on ClinicalTrials.gov under NCT04857242. Informed consent was obtained from the next of kin of the patient included in this study. The research related to human use complies with all the relevant national regulations, institutional policies and was performed in accordance with the tenets of the Helsinki Declaration.
: Written informed consent for the publication of clinical details and images was obtained from the next of kin of the patient. A copy of the consent form is available for review by the journal editor.
: ZZ received consultant fee from Dräger Medical AG. RC, AL, PB, TM, FH, BB, JC, SR and KM have nothing to disclose.